News
China 1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman Sachs
Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China 1 strategy materialising emerge, according to a ...
39m
Stocktwits on MSNTesla Robotaxi Launch: Goldman Sachs Lists 3 Reasons Why Cybercab Scaling Will Be SlowGoldman Sachs has raised concerns about the near-term prospects of Tesla’s newly launched robotaxi service, Cybercab, despite ...
HDB Financial Services IPO Day 1 | GMP Live Updates| HDB Financial Services, the retail lending arm of HDFC Bank, will launch ...
55m
Cryptopolitan on MSNBitGo’s assets under custody jumped to $100B in H1 2025The value of digital assets under BitGo Inc.’s custody has surged. BitGo’s vice president for its Asia-Pacific business, Abel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results